Stable Cell Line

Are long timelines, inconsistent results, and low yields slowing down your monoclonal antibody development? AtaGenix accelerates your journey with our advanced Verified In-Situ Plate Seeding (VIPS™) technology, cutting development time by over 50% while ensuring clonality reports critical for IND submission. Our IP-free, royalty-free cell lines are designed for stability and high productivity, achieving yields exceeding 7g/L. With decades of expertise and a track record of generating 100+ stable cell lines, we provide a robust platform optimized for developability. Boost your research and bioproduction with AtaGenix’s innovative solutions.

AtaGenix streamlines stable cell line generation with high-efficiency solutions for biopharmaceutical development. Using VIPS™ technology, we accelerate projects by 50%, ensuring monoclonality with high-resolution imaging. Our process delivers yields exceeding 7g/L, supporting long-term stability. We offer IP-free cell lines (CHO-1, CHO-S, CHO-DG44, HEK293) and developability-focused testing to minimize production risks. With 15+ years of expertise, 500+ monoclonal antibodies developed, and 100+ stable cell lines generated, we ensure seamless cGMP-ready technology transfer. AtaGenix—your trusted partner for scalable bioproduction.